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Mast cells are abundant at the periphery of the majority
of solid tumors where they typically promote angiogen-
esis and enhance tumor growth. However, there is some
evidence from epidemiological studies that allergic dis-
ease reduces cancer risk. In the context of infection,
mast cell activation with Toll-like receptor (TLR) ago-
nists induces the production of multiple mediators
which mobilize and activate known anti-tumor effector
cells. TLR agonists can also be effective in tumor immu-
notherapy. We demonstrate that the TLR2 agonist
Pam3CSK4 is tumor inhibitory and mediates its effects
via mast cell activation and reversal of the normal pro-
tumorigenic activity of mast cells. TLR2 agonist treat-
ment decreased B16.F10 tumor growth in wild-type
mice, but not in mast cell deficient Kit
W-sh/W-sh mice.
Tumor growth inhibition following TLR2 agonist
administration was restored in Kit
W-sh/W-sh mice by
local reconstitution with wild-type, but not TLR2-defi-
cient mast cells. Mast cell dependent tumor growth
inhibition occurred independently of tumor necrosis fac-
tor (TNF) production and was not associated with direct
tumor cytotoxicity or degranulation in vitro.T u m o r
growth inhibition was associated with mast cell depen-
dent recruitment of natural killer (NK) and T cells. This
study demonstrates that local mast cell activation pro-
vides a novel opportunity to modify the tumor microen-
vironment for successful cancer immunotherapy.
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